Drug pricing review group signs deal with Aetion for patient data

The Institute for Clinical and Economic Review (ICER), a small but influential Boston-based research group, has signed a deal with private technology company Aetion to help it use patient health data in its reports on whether individual drugs are priced properly.

from Reuters: U.S. https://ift.tt/37XcEXs